The FDA has accepted Stealth…
The FDA has accepted Stealth BioTherapeutics’ third new drug application [...]
Gilead has become the latest…
Gilead has become the latest pharma to strengthen its in [...]
Dynavax’s lofty ambition to…
Dynavax’s lofty ambition to snatch Shingrix’s crown got off to [...]
The FDA has freed Rocket…
The FDA has freed Rocket Pharmaceuticals from a clinical hold, [...]
Xoma Royalty is ravenous for…
Xoma Royalty is ravenous for biotechs, and the Bay Area [...]
The first half of 2025 was brutal…
The first half of 2025 was brutal for biotech, but [...]
Despite missing its primary…
Despite missing its primary endpoint in a phase 3 study, [...]
Viking Therapeutics has reported…
Viking Therapeutics has reported phase 2 data on its oral [...]
Delays from the Food and Drug…
Delays from the Food and Drug Administration continue to pile [...]
Gene therapy biotech Kriya…
Gene therapy biotech Kriya Therapeutics has secured $313 million in [...]